4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Exactech Shoulder Post Market Clinical Follow-up StudyAxial Spondyloarthritis, Crystal Arthropathies, Infections, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Rotator Cuff Injuries, Rotator Cuff Tear Arthropathy, Rotator Cuff Tears, Rupture, Shoulder Injuries, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, Tendon Injuries, ankylosing spondylitis, ankylosis, arthritic joint disease, arthropathy, autoimmune disease, bone disorder, bone fracture, chondrocalcinosis, connective tissue disorder, immune system disorder, injury, musculoskeletal system disorder, osteonecrosis, rheumatic disorder, rheumatoid arthritis, spondylitis, vertebral column disorderRecruitingNot stated2026-09-17NCT05603728
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorderRecruitingPhase 32026-09-09NCT07753993
Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus NephritisFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, nephritis, systemic lupus erythematosus, urinary system disorderActive, not recruitingPhase 32026-07-31NCT05138133
Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in ItalyDyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, metabolic diseaseRecruitingNot stated2026-01-22NCT05430828